WC
STIM icon

Wexford Capital’s Neuronetics STIM Stock Holding History

Wexford Capital’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Buy
2,002,625
+1,301,664
+186% +$1.89M 0.33% 37
2026
Q1 		$1.02M Buy
700,961
+56,010
+9% +$88.8K 0.15% 61
2025
Q4 		$890K Sell
644,951
-532,274
-45% -$1.11M 0.17% 80
2025
Q3 		$3.21M Buy
1,177,225
+534,155
+83% +$1.9M 0.46% 23
2025
Q2 		$2.24M Buy
643,070
+171,345
+36% +$676K 0.63% 31
2025
Q1 		$1.74M Buy
+471,725
New +$1.72M 0.45% 48

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Wexford Capital's STIM Position: Q2 2026 in Review

Wexford Capital increased its Neuronetics (STIM) stake by 186% in Q2 2026, buying an estimated $1.89M and bringing the position to 2,002,625 shares worth $2.6M. The position accounts for 0.33% of the portfolio, ranked #37.

Wexford Capital first reported a position in STIM in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.21M in Q3 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Wexford Capital held 2,002,625 shares of Neuronetics worth $2.6M as of Q2 2026.
  • Wexford Capital bought 1,301,664 Neuronetics shares in Q2 2026, an estimated $1.89M.
  • Neuronetics made up 0.33% of Wexford Capital's portfolio in Q2 2026, its #37 holding.
  • Wexford Capital first reported a position in Neuronetics in Q1 2025 and has held it in 6 quarters since.
  • Wexford Capital's Neuronetics position peaked at $3.21M in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Wexford Capital's 13F filing for Q2 2026, filed 14 Aug 2026.